首页> 中文期刊> 《中国医学科学杂志:英文版》 >HLA-DRB GENES POLYMORPHISM IN CHINESE NORTHERN PATIENTS WITH ATOPIC ASTHMA

HLA-DRB GENES POLYMORPHISM IN CHINESE NORTHERN PATIENTS WITH ATOPIC ASTHMA

         

摘要

Objective. Atopic asthma provides a useful model for evaluating the genetic factors that control human immune responsiveness. HLA class Ⅱ gene products are involved in the control of immune response. As HLA-DRB gene is the most polymorphic HLA class Ⅱ gene, we investigated whether susceptibility or resistance to the disease is associated with HLA-DRB. Methods. Blood samples were obtained from two groups of unrelated Chinese northern adults: (l) 50 atopic asthma (7 of them with familial aggregation) ;(2) 80 healthy controls without asthma or atopy and other HLA-associated diseases. Genomic DNA was extracted from peripheral venous blood leucocytes. The polymorphic second exon of HLA-DRB gene was amplified by sequence-specific primer polymerase chain reaction (SSP/PCR) methods. All patients had their serum IgE (total and specific) antibody levels by RAST, bronchial reactivity assessed by methacholine brocho-provocation test and/or bronchodilation test. Results. There was an increased gene frequency of DR6(13) and DR52 in asthmatic subjects compared with healthy subjects(17% vs 4. 3%, P<0.01; 50% vs 17. 5 %, P<0. 01 ), and the decreased frequency of DR2(15) and DR51 in asthmatic patients(7% vs 18%, P<0. 05; 2 % vs 33 %, P<0. 01 ). We found the positive association between DR6(13)-DR52 and sIgE antibody responsiveness to dl (from house dust mite al- lergen ); negative association between HLA-DRB alleles and TIgE or BHR (bronchial hyperresponsiveness ). Conclusion. The results suggested that HLA haplotype DR6(13)-DR52 was significantly implicated in sus- ceptibility to house dust mite induced-asthma, at least it would be more closely associated with atopic asth- ma. Conversely, alleles DR2(15) and DR51 might confer protection against the disease. HLA-DRB genes were particularly involved in regulating human atopic immune response in asthma.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号